The Jellyfish Times

( 0 Votes )

Friday, 03 December 2010 20:31

Madison, Wisconsin, December 2010 — A new supplement, available without prescription and with no side effects, is quietly building a positive stir among its users, and in others interested in finding out more about what it can do. www.prevagen.com/newsletter/ The basis of the supplement is a jellyfish protein that in university-level research has proven to help protect brain cells from the ravages of aging, and in some cases, easing the suffering attributed to autoimmune disease. It’s called Prevagen and is manufactured by Quincy Bioscience, a Madison-based biotechnology company focused on the development of health applications from this protein source. Part of their success — beyond the discovery and excellent science that’s being applied to it, is their open communication and willingness to thoroughly inform the public about what they’re doing. When a member of the company’s staff interacts with someone calling in with an inquiry, they readily answer questions. They also, with permission, post unsolicited testimonials on their Web site, and conduct ongoing market research, explaining their methodology openly, and then sharing their findings. To enlarge upon that communication and to further increase the bond between the company, its customers and customers-to-be, Quincy Bioscience has created a one-page newsletter that is planned for weekly delivery by e-mail. They named it The Jellyfish Times. Each issue of The Jellyfish Times is anchored with a lead article about 250 words in length, written in a stimulating and fun style, and introducing, discussing or providing information that will help the reader get the most out of life as he/she ages. Targeted primarily to Baby Boomers (those born between 1946 and 1964,) but of interest to any adult regardless of age, the reader will also find sidebars containing basic facts, humorous takes on history, coupons and other useful and meaningful material. To find out more about The Jellyfish Times, go to http://www.prevagen.com/newsletter/. SOURCE: Quincy Bioscience < Prev   Next >